Simulation of two-phase flows at large density ratios and high Reynolds numbers using a discrete unified gas kinetic scheme

In order to treat immiscible two-phase flows at large density ratios and high Reynolds numbers, a three-dimensional code based on the discrete unified gas kinetic scheme (DUGKS) is developed, incorporating two major improvements. First, the particle distribution functions at cell interfaces are reconstructed using a weighted essentially non-oscillatory scheme. Second, the conservative lower-order Allen-Cahn equation is chosen, instead of the higher-order Cahn-Hilliard equation, to evolve the free-energy based phase field governing the dynamics of two-phase interfaces. Five benchmark problems are simulated to demonstrate the capability of the approach in treating two phase flows at large density ratios and high Reynolds numbers, including three two dimensional problems (a stationary droplet, Rayleigh-Taylor instability, and a droplet splashing on a thin liquid film) and two three-dimensional problems (binary droplets collision and Rayleigh-Taylor instability). All results agree well with the previous numerical and the experimental results. In these simulations, the density ratio and Reynolds number can reach a large value of O(1000). Our improved approach sets the stage for the DUGKS scheme to handle realistic two-phase flow problems

Strangeon matter and strangeon stars in a linked bag model

Inspired by various astrophysical phenomenons, it was suggested that pulsar-like compact stars may in fact be strangeon stars, comprised entirely of strangeons (quark-clusters with three-light-flavor symmetry) and a small amount of electrons. To examine such possibilities, in this work we propose a linked bag model, which can be adopted for strong condensed matter in both 2-flavoured (nucleons) and 3-flavoured (hyperons, strangeons, etc.) scenarios. The model parameters are calibrated to reproduce the saturation properties of nuclear matter, which are later applied to hyperonic matter and strangeon matter. The obtained energy per baryon of strangeon matter is reduced if we adopt larger quark numbers inside a strangeon, which stiffens the equation of state and consequently increases the maximum mass of strangeon stars. In a large parameter space, the maximum mass and tidal deformability of strangeon stars predicted in the linked bag model are consistent with the current astrophysical constraints. It is found that the maximum mass of strangeon stars can be as large as $\sim 2.5M_\odot$, while the tidal deformability of a $1.4M_\odot$ strangeon star lies in the range of $180\lesssim \Lambda_{1.4} \lesssim 340$. More refined theoretical efforts as well as observational tests to these results are necessary in the future

Asprellcosides B of Ilex asprella Inhibits Influenza A Virus Infection by Blocking the Hemagglutinin- Mediated Membrane Fusion

Ilex asprella is routinely used in China as a traditional medicinal herb to treat influenza (Flu). However, its specific antiviral activity and underlying molecular mechanism have not yet been determined. In this study, we sought to determine the antiviral activity and mechanism of Asprellcosides B, an active component extracted from Ilex asprella, and used against the influenza A virus cell culture. We also performed a computer-assisted structural modeling analysis and carried out surface plasmon resonance (SPR) experiments in the hope of determining the viral target of Asprellcosides B. Results from our studies show that Asprellcosides B reduced virus replication by up to 63% with an IC50 of about 9 μM. It also decreased the low pH-induced and virus-mediated hemolysis by 71% in vitro. Molecular docking simulation analysis suggested a possible binding of Asprellcosides B to the hemagglutinin (HA), which was confirmed by a surface plasmon resonance (SPR) assay. Altogether, our findings demonstrate that Asprellcosides B inhibits the influenza A virus, through a specific binding to the HA, resulting in the blockade of the HA-mediated membrane fusion

Spectroelectrochemical flow cell with temperature control for investigation of electrocatalytic systems with surface-enhanced Raman spectroscopy

We describe a method for investigating the reaction mechanism of fuel cell systems by designing a spectroelectrochemical cell with functions of temperature and flow control to mimic the reaction condition of fuel cell systems and utilizing Au core Pt shell (Au@Pt) nanoparticles to enhance the Raman signal of the surface species on the surface of electrocatalysts. The cell consists of three parts: a thin-layer spectroelectrochemical reaction chamber with an optical window for Raman measurement, the heating chamber right beneath the reaction chamber, and a long spiral flow channel to preheat the solution to the desired temperature and effectively exchange the solution. The temperature of the solution can be easily controlled from room temperature to 80 degrees C, and the flow rate can be as high as 945 mu l s(-1). The temperature and flow control is demonstrated by monitoring the changes in the cyclic voltammograms and the Raman signals. By synthesizing Au@Pt nanoparticles and assembling them on a Pt substrate, we can significantly enhance the Raman signal of surface species on the Pt shell surface, which allows us to detect strong signal of CO as the dissociative product of formic acid as well as the intermediate species of the oxidation process. The further development and perspectives of using SERS to study the electrocatalytic systems are discussed

PinX1 regulation of telomerase activity and apoptosis in nasopharyngeal carcinoma cells

<p>Abstract</p> <p>Background</p> <p>Human interacting protein X1 (PinX1) has been identified as a critical telomerase inhibitor and proposed to be a putative tumor suppressor gene. Loss of PinX1 has been found in a large variety of malignancies, however, its function in inhibiting telomerase activity of tumor cells is not well documented. Here we show that PinX1 is essential for down-regulation telomerase activity of nasopharyngeal carcinoma.</p> <p>Methods</p> <p>Expression vectors of human PinX1 (pEGFP-C3-PinX1) and its small interfering RNA (PinX1-FAM-siRNA) were constructed and transfected into NPC. Their effects on mRNA of telomerase catalytic subunit (hTERT), telomerase activity, cell proliferation, cell migration, wound healing, cell cycles and apoptosis were examined using semi-quantitative RT-PCR, stretch PCR, MTT assay, Transwell, scratch assay and flow cytometry, respectively.</p> <p>Results</p> <p>Transfection of pEGFP-C3-PinX1 and PinX1-FAM-siRNA increased and reduced PinX1 mRNA by 1.6-fold and 70%, respectively. Over-expression of PinX1 decreased hTERT mRNA by 21%, reduced telomerase activity, inhibited cell growth, migration and wound healing ability, arrested cells in G0/G1 phase, and increased apoptotic index. In contrast, down-regulation of PinX1 did not alter the above characteristics.</p> <p>Conclusions</p> <p>PinX1 may play important roles in NPC proliferation, migration and apoptosis and has application potential in tumor-targeted gene therapy.</p

Vitamin D Signaling through Induction of Paneth Cell Defensins Maintains Gut Microbiota and Improves Metabolic Disorders and Hepatic Steatosis in Animal Models.

Metabolic syndrome (MetS), characterized as obesity, insulin resistance, and non-alcoholic fatty liver diseases (NAFLD), is associated with vitamin D insufficiency/deficiency in epidemiological studies, while the underlying mechanism is poorly addressed. On the other hand, disorder of gut microbiota, namely dysbiosis, is known to cause MetS and NAFLD. It is also known that systemic inflammation blocks insulin signaling pathways, leading to insulin resistance and glucose intolerance, which are the driving force for hepatic steatosis. Vitamin D receptor (VDR) is highly expressed in the ileum of the small intestine, which prompted us to test a hypothesis that vitamin D signaling may determine the enterotype of gut microbiota through regulating the intestinal interface. Here, we demonstrate that high-fat-diet feeding (HFD) is necessary but not sufficient, while additional vitamin D deficiency (VDD) as a second hit is needed, to induce robust insulin resistance and fatty liver. Under the two hits (HFD+VDD), the Paneth cell-specific alpha-defensins including α-defensin 5 (DEFA5), MMP7 which activates the pro-defensins, as well as tight junction genes, and MUC2 are all suppressed in the ileum, resulting in mucosal collapse, increased gut permeability, dysbiosis, endotoxemia, systemic inflammation which underlie insulin resistance and hepatic steatosis. Moreover, under the vitamin D deficient high fat feeding (HFD+VDD), Helicobacter hepaticus, a known murine hepatic-pathogen, is substantially amplified in the ileum, while Akkermansia muciniphila, a beneficial symbiotic, is diminished. Likewise, the VD receptor (VDR) knockout mice exhibit similar phenotypes, showing down regulation of alpha-defensins and MMP7 in the ileum, increased Helicobacter hepaticus and suppressed Akkermansia muciniphila. Remarkably, oral administration of DEFA5 restored eubiosys, showing suppression of Helicobacter hepaticus and increase of Akkermansia muciniphila in association with resolving metabolic disorders and fatty liver in the HFD+VDD mice. An in vitro analysis showed that DEFA5 peptide could directly suppress Helicobacter hepaticus. Thus, the results of this study reveal critical roles of a vitamin D/VDR axis in optimal expression of defensins and tight junction genes in support of intestinal integrity and eubiosis to suppress NAFLD and metabolic disorders

Pharmacokinetic Interaction between Magnolol and Piperine in Rats

Purpose: To investigate the pharmacokinetic mechanism of interaction between magnolol and piperine when co-administered to rats.Methods: The rats were divided into five groups as follows: magnolol group (625 mg/kg); low dose of piperine group (20 mg/kg); high dose of piperine group (40 mg/kg); low dose of piperine + magnolol group; or high dose of piperine + magnolol group. Plasma samples were collected at regular time intervals after administration of a single dose of magnolol (625 mg/kg, p.o.) alone or piperine (20 or 40 mg/kg, p.o.) in the presence or absence of magnolol (625 mg/kg, p.o.). The concentrations of magnolol and piperine in plasma were measured by a validated high performance liquid chromatography (HPLC) method.Results: Compared with control, the groups given magnolol alone, concomitant administration of piperine and magnolol resulted in significant decrease (p &lt; 0.01) in the AUC and Cmax of magnolol. Interestingly, compared with administration of piperine alone (20 mg/kg), co-administration with magnolol did not significantly (p &gt; 0.05) alter the pharmacokinetic parameters of piperine. However, at high dose (40 mg/kg) of piperine, Cmax of piperine significantly decreased from 4.30 ± 1.47 to 2.50 ± 0.78 μg/mL (p &lt; 0.05).Conclusion: Co-administration of magnolol and piperine decreases plasma concentration of either drug in rats, suggesting that concurrent use of magnolol with piperine or piperine-containing diets would require close monitoring for potential interactions.Keywords: Magnolol, Piperine, Pharmacokinetic interaction, Co administratio